SMALL CELL LUNG CANCER (SCLC)
Clinical trials for SMALL CELL LUNG CANCER (SCLC) explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER (SCLC) trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER (SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to slow aggressive lung cancer
Disease control Not yet recruitingThis study tests a new treatment for people with extensive-stage small cell lung cancer who have not had treatment before. It combines the experimental drug bemotuzumab with standard chemotherapy and anlotinib, followed by chest radiation. The goal is to see if this approach can …
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New combo therapy aims to tame tough lung cancer
Disease control Not yet recruitingThis study tests how well people with small cell lung cancer tolerate a new drug, alisertib, when added to standard chemotherapy (paclitaxel). About 50 adults who have already tried at least one prior treatment will take alisertib pills twice daily for a week, plus IV paclitaxel …
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Experimental combo targets rare lung cancer transformation
Disease control Not yet recruitingThis early-stage trial tests whether combining two drugs, lurbinectedin and osimertinib, is safe and works against a rare lung cancer called transformed small cell lung cancer. It is for adults whose cancer changed from a common type after prior treatment. The study will check fo…
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE1, PHASE2 • Sponsor: Misty Shields • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Repurposed antipsychotic drug shows promise against tough cancers
Disease control Not yet recruitingThis study tests penfluridol, a drug originally used for mental health, in 33 adults with relapsed small cell lung or cervical cancer. The goal is to see if it can shrink tumors or slow disease progression. Participants take the drug once a week by mouth, and the study will find …
Matched conditions: SMALL CELL LUNG CANCER (SCLC)
Phase: PHASE1, PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC